A carregar...

Blinatumomab: Enlisting serial killer T cells in the war against hematologic malignanciess

INTRODUCTION: The approval of blinatumomab signals the long awaited arrival of immunotherapy for acute lymphoblastic leukemia (ALL). Previous options for relapsed or refractory disease were restricted to combination cytotoxic chemotherapy with limited efficacy and significant toxicity. Through an in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Expert Opin Biol Ther
Main Authors: Rogala, Britny, Freyer, Craig W., Ontiveros, Evelena P., Griffiths, Elizabeth A., Wang, Eunice S., Wetzler, Meir
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4994468/
https://ncbi.nlm.nih.gov/pubmed/25985814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.1041912
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!